Trial intelligence / Profile preview

Dysport Spread and Effectiveness in CP Spastic Equinus

NCT01276015Phase 4Completed

Sponsor
Università degli Studi di Verona
Start
Dec 2009
Primary completion
Feb 2010
Modality
Recombinant Proteins and Enzymes
01

Overview

A Phase 4 trial of botulinum toxin type A in cerebral palsy (CP), sponsored by Università degli Studi di Verona. Started Dec 2009; status: completed.

02

Drugs

botulinum toxin type A
03

Conditions

cerebral palsy (CP)

Beyond the preview

Go deeper on NCT01276015.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01276015.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call